| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/15/2004 | WO2004058261A1 Antibacterial water-based preparation |
| 07/15/2004 | WO2004058144A2 Antibacterial agents |
| 07/15/2004 | WO2004058142A2 Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses |
| 07/15/2004 | WO2004046109A3 Ionene oligomers and polymers |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004041158A3 Rifalazil compositions and therapeutic regimens |
| 07/15/2004 | WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004019911A3 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 07/15/2004 | WO2004016653A3 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003075852A3 Antibiotic composition |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003051912A9 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 07/15/2004 | US20040138459 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 07/15/2004 | US20040138449 Antiviral agents |
| 07/15/2004 | US20040138437 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138248 adjustment immunology response; induce biosynthesis of cytokines; viricides; anticancer agents |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | US20040138171 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 07/15/2004 | US20040138157 Activation of biosynthesis of Dna; adjust concentration of pyrimidine; using orotic acid, uracil or cytosine |
| 07/15/2004 | US20040138153 enzyme inhibitors; drug screening |
| 07/15/2004 | US20040138149 slurrying; precipitation; for treatment of bacterial infections |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138109 Viricides such as ciluprevir in solutions of polyethylene glycol, ethanol, propylene glycol, water and/or mixtures, used for prophylaxis or prevention of hepatitis C virus (HCV) infections |
| 07/15/2004 | US20040138108 Pro-drug and use thereof as a medicament |
| 07/15/2004 | US20040138107 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137568 for treatment of infection by injection of dose between 1x103 and 1x107 bacteria per kg |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137436 Method for measuring drug resistance |
| 07/15/2004 | US20040137426 Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells |
| 07/15/2004 | US20040137156 for sustained release; compressed tablets/capsules |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137088 Improved, color-stable extract of St John's wort having reduced or absent amounts of chorophyll and proanthocyanidins; gels for skin disorders and mucous membrane irritations; acne, atopic dermatitis; neurodermatitis; bactericides; viricides |
| 07/15/2004 | US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040137009 DNA encoding a derivative of a human interferon- alpha selected from DNA encoding a protein in which one or more amino acid residues of the protein encoded by the above DNA have been replaced, deleted, and/or added |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 07/15/2004 | US20040136962 Ordered molecular presetation of antigens, method of preparation and use |
| 07/15/2004 | US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma |
| 07/15/2004 | US20040136922 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 07/15/2004 | US20040136918 salmeterol xinafoate and fluticasone propionate in a metered does inhaler with propellant |
| 07/15/2004 | DE10300222A1 Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen The use of active substances for the prophylaxis and / or therapy of viral diseases |
| 07/15/2004 | DE10300109A1 Methode zur Inhibition der Replikation von Herpesviren Method for inhibiting the replication of herpes viruses |
| 07/15/2004 | CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2512190A1 Benzoquinolizine-2-carboxylic acid-containing compositions |
| 07/14/2004 | EP1437408A1 Novel antisense oligonucleotide derivatives against hepatitis c virus |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437362A1 Macrocyclic peptides inhibiting the hepatitis C virus ns3 protease |
| 07/14/2004 | EP1437359A2 Novel 3,6-Hemiketals from the Class of 9a-Azalides |
| 07/14/2004 | EP1437354A1 4-oxoquinolizine antimicrobials having 2-pyridone skeleton as partial structure |
| 07/14/2004 | EP1437352A1 Benzimidazole compound, process for producing the same, and use thereof |
| 07/14/2004 | EP1437349A1 Substituted isoxazoles and the use thereof as antibiotics |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1437134A1 Anti-influenza drugs |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436380A2 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 07/14/2004 | EP1436345A1 Quaternary polyamidoamines, the production thereof, corresponding agents and the use thereof |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |